NSW blood borne virus research & evaluation program

The Centre for Population Health (CPH), NSW Ministry of Health is funding a blood borne virus research and evaluation program for HIV, sexually transmissible infections (STIs) and viral hepatitis for five years between 1 January 2025 to 30 December 2029.

The blood borne virus research program is funded by NSW Health to undertake policy-relevant research to support NSW Health in reducing blood borne viruses (BBV) and STIs in NSW, as well as improving the health outcomes of people living with these infections.

About the blood borne virus research program

The program will provide evidence-based, policy-relevant and program level solutions to support the NSW population health response to HIV, STIs and viral hepatitis. The program will also provide strategic advice based on national and international data, enabling NSW Health to effectively address new and emerging issues and policy-relevant priorities.

Strategic goals of the blood borne virus research program

This research program aims to bring together leading researchers to support the following strategic goals:

  • prevent new infections through harm reduction, education and health promotion
  • increase access and testing for people at risk of BBV and STI infection
  • treat infections rapidly and effectively, and link newly acquired and existing infections into treatment and care, and
  • reduce stigma and discrimination as a barrier to prevention, testing, and treatment of infections.

The program will guide efforts to improve the health of affected communities and priority populations by undertaking research and program evaluation, and providing evidence and strategic advice to support policy and program development.

Scope of work

The blood borne virus research and evaluation program will be an independent program located within an academic setting. The program will need to:

  • Attract and retain high quality researchers and project officers
  • Demonstrate linkages with groups with relevant expertise
  • Have networks and partnerships to support best practice approaches
  • Support development of population health research skills in priority areas
  • Conduct small and large-scale program evaluations
  • Engage in co-production and partnership with affected stakeholders
  • Technology and resources to manage complex data from various sources.
  • Provide recommendations for program and policy activity in BBVs & STIs

Assistance with your tender

The blood borne virus research tender was released on 11 June 2024, and closes on 16 July 2024. The tenders will be evaluated from July to September. The contract will be awarded in October 2024. If you need help with your proposal Madrigal Communications can assist. We have experience of medical, allied health and research tenders.